Mutiny in Scrutiny?

The House bill has passed — barely and belatedly — and it is now dead. Nothing like it will ever pass the Senate. The question now is whether anything will, now that the voters have spoken in New Jersey and Virginia — and now that the exceedingly narrow margin in the House will likely invite even greater scrutiny of that which is being proposed.

Greater scrutiny will not help the Democrats’ efforts. In truth, their hopes for passage largely hinge on successfully hiding two plain facts from the voters: One, the House Republicans and the Congressional Budget Office have now shown that a bill costing $61 billion can lower Americans’ insurance premiums, while bills costing $1.7 trillion cannot (and instead would raise them substantially). Two, the Democrats’ plans would be paid for only if they follow through on plans to siphon hundreds of billions of dollars out of already-barely-solvent Medicare, and to do so just in time for the baby boomers’ retirement.

Given the magnitude of the challenge of continuing to hide these plain facts from an increasingly attentive citizenry, the Democratic health-care train has a very bumpy ride ahead — as it rolls into the chamber that the American Founders thought from the beginning would ultimately decide our fate: the Senate.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top